Core Insights - Apple Inc. has received FDA clearance for its hypertension detection system for the Apple Watch, set to launch next week in 150 countries and regions [1][2] - The hypertension feature utilizes data from the Apple Watch's optical heart sensor to monitor blood vessel responses over a 30-day period, alerting users to potential chronic hypertension [2][3] - The introduction of this feature is part of Apple's strategy to enhance its health offerings amid growing competition from companies like Garmin, Samsung, and Oura Health [3] Company Developments - The hypertension detection tool will be available on Apple Watch Series 9, Series 10, Series 11, Ultra 2, and Ultra 3 [2] - Apple developed the new feature using advanced machine learning and data from studies involving over 100,000 participants [3] Industry Context - Approximately 1.3 billion adults globally are affected by hypertension, which is a significant risk factor for various health issues [4] - The consumer hardware sector is increasingly integrating sophisticated health tracking tools into fitness bands and smartwatches, blurring the lines between wearable technology and medical devices [4] - Whoop Inc. is facing regulatory challenges regarding its blood pressure tracking tool, highlighting the scrutiny that health-related features in consumer devices are under [5]